Product
Ferric Carboxymaltose
Aliases
Ferinject, Ferric Carboxymaltose Injection, Ferric Carboxymaltose Injection [Ferinject]
Name
Injectafer
INN Name
Ferric Carboxymaltose Injection
FDA Approved
Yes
9 clinical trials
1 organization
15 indications
1 document
Indication
Iron DeficiencyIndication
AnemiaIndication
Congestive Heart FailureIndication
Iron-deficiencyIndication
Ultra short termIndication
Iron Deficiency AnemiaIndication
ScoliosisIndication
systolicIndication
Heart Failure with NYHA Class IIIndication
Vitamin D DeficiencyIndication
Gynecological CarcinomaIndication
Colon CancerIndication
Hypoferritenemia Without Anemia (HWA)Indication
Iron Deficiency Without AnemiaClinical trial
A Randomized, Open-label, Parallel, Two-treatment, Single-dose Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia Under Fasting ConditionsStatus: Completed, Estimated PCD: 2024-01-22
Clinical trial
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron DeficiencyStatus: Completed, Estimated PCD: 2023-02-02
Clinical trial
Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis CorrectionStatus: Active (not recruiting), Estimated PCD: 2024-11-30
Clinical trial
Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron DeficiencyStatus: Not yet recruiting, Estimated PCD: 2025-04-01
Clinical trial
Effect of IV Iron (Ferric Carboxymaltose, Ferinject) on Exercise Tolerance, Symptoms and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) and Iron Deficiency With and Without Anaemia.Status: Completed, Estimated PCD: 2022-12-13
Clinical trial
Perioperative Management With Ferric Carboxymaltose and Tranexamic Acid to Reduce Transfusion Rate in Gynaecological Carcinoma Surgery: a Single-blind, Mono-centre, Randomized TrialStatus: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
Preoperative i.v. Iron Substitution in Patients With Colon Carcinoma and Iron-deficiency AnemiaStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron DeficiencyStatus: Terminated, Estimated PCD: 2022-04-04
Clinical trial
Hypoferritinemia Without Anemia Among Reproductive Age Females: Frequency, Determinants and Treatment OutcomesStatus: Active (not recruiting), Estimated PCD: 2024-10-01
Document
DailyMed Label: InjectaferOrganization
American Regent, Inc.